Showing results for "#Corbevax"
Biological E's Corbevax gets WHO emergency use authorisation
BE supplied 100 million doses of Corbevax to the Indian government, which were then utilised in pan-India immunisation campaigns; mainly in 12 to...
Corbevax Covid vaccine is safe, offers high antibody levels: NTAGI...
India's third homegrown COVID-19 vaccine Corbevax is safe and offers good immunogenicity and higher antibody levels than some other vector vaccines.
DCGI gives final approval to Covid vaccine Corbevax for 12-18 year...
Hyderabad-based pharmaceutical company Biological E on Monday received final approval from Drugs Controller General of India (DCGI) for its Covid...
Govt panel recommends EUA for Corbevax in 5-11 age group
The SEC has also recommended the grant of emergency use authorisation (EUA) to Cadila for their ZyCoV-D vaccine for an additional dose of 3mg with a...
Over 3 cr children of 12-14 years administered vaccine first dose
The vaccination for children between the 12-14 age group started on March 16 with Biological E’s intramuscular vaccine Corbevax, which is administered...
DCGI approves Corbevax as first heterologous booster shot for adults
The BE's Corbevax is the first such vaccine in India to be approved as a heterologous COVID-19 booster. Recently, BE has furnished its clinical trials...
Centre to soon approve Corbevax as booster
The approval will be based on the recommendations made by the COVID-19 Working Group of the National Technical Advisory Group on Immunisation (NTAGI)...
Corbevax administered as booster dose in Tamil Nadu
In the State, around 95.95 per cent eligible persons took the first dose Covid vaccine and 89.41 per cent persons took second doses.
